Predicate |
Object |
contentType |
Clinical Trial, Phase III|Comparative Study|Multicenter Study|News|Randomized Controlled Trial |
endingPage |
8 |
issn |
1087-2914 |
issueIdentifier |
8 |
pageRange |
607-8 |
publicationName |
AIDS patient care and STDs |
startingPage |
607 |
bibliographicCitation |
Second tenofovir phase III study for the chronic HBV reaches primary endpoint. AIDS Patient Care STDS. 2007 Aug;21(8):607–8. PMID: 17907310. |
date |
200708 |
identifier |
https://pubmed.ncbi.nlm.nih.gov/17907310 |
isPartOf |
https://portal.issn.org/resource/ISSN/1087-2914 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21399 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ |
title |
Second tenofovir phase III study for the chronic HBV reaches primary endpoint |
discusses |
http://id.nlm.nih.gov/mesh/M0571031 http://id.nlm.nih.gov/mesh/M0278180 http://id.nlm.nih.gov/mesh/M0254881 http://id.nlm.nih.gov/mesh/M0028839 http://id.nlm.nih.gov/mesh/M0028255 http://id.nlm.nih.gov/mesh/M0000347 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D019380Q000008 http://id.nlm.nih.gov/mesh/D019380Q000627 http://id.nlm.nih.gov/mesh/D000225Q000031 http://id.nlm.nih.gov/mesh/D063065Q000008 http://id.nlm.nih.gov/mesh/D018894Q000008 http://id.nlm.nih.gov/mesh/D063065Q000627 http://id.nlm.nih.gov/mesh/D063065Q000009 http://id.nlm.nih.gov/mesh/D018894Q000627 http://id.nlm.nih.gov/mesh/D018894Q000009 http://id.nlm.nih.gov/mesh/D019694Q000188 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D000225Q000627 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D000225Q000009 http://id.nlm.nih.gov/mesh/D000225Q000008 http://id.nlm.nih.gov/mesh/D000068698 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016896 |